Xilonix Overview

Reviewed: October 3, 2014

Xilonix is currently in phase III studies in the United States and Europe for the treatment of colorectal cancer.

Currently, Xilonix, is being evaluated in advanced colorectal cancer patients with cachexia. Cancer cachexia is a term used to describe a syndrome of progressive weight loss, anorexia, and a loss of skeletal muscle mass due to a malignant growth.

Xilonix is being manufactured by XBiotech USA, Inc., a company in Austin, Texas. XBiotech is a leading developer of biological therapies—including the discovery and development of True Human antibodies.

XBiotech is looking to start manufacturing and shipping Xilonix by early 2016.

Xilonix is a "True Human" monoclonal antibody and targets interleukin-alpha1. Xilonix works by stopping the growth of cancer cells.


Patient Ratings for

How was your experience with ?

First, a little about yourself

Tell us about yourself in a few words?

What tips would you provide a friend before taking ?

What are you taking for?

Choose one
  • Other

How long have you been taking it?

Choose one
  • Less than a week
  • A couple weeks
  • A month or so
  • A few months
  • A year or so
  • Two years or more

How well did work for you?

Did you experience many side effects while taking this drug?

How likely would you be to recommend to a friend?


Xilonix Drug Class

Xilonix is part of the drug class: